Mendelian randomization: Loosening the Gordian knot of testosterone and male ageing

Asian Journal of Andrology

Volumn 15, Issue 5, 2013, Pages 579-581

  Handelsman, David J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

AGING; ANALYTIC METHOD; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ANDROPAUSE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; COMORBIDITY; CROSS-SECTIONAL STUDY; GENETIC POLYMORPHISM; HEREDITY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOPHYSIS TESTIS SYSTEM; IMMUNOASSAY; MENDELIAN RANDOMIZATION ANALYSIS; METABOLIC CLEARANCE RATE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; PREDICTOR VARIABLE; STEROID ANALYSIS;

CARDIOVASCULAR DISEASES; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; TESTOSTERONE;

EID: 84883470738     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2013.71     Document Type: Article

References (25)

1. Corona G, Rastrelli G, Monami M, Guay A, Buvat J et al. Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-Analytic study. Eur J Endocrinol 2011; 165: 687-701
2. Ruige JB, Mahmoud AM, de Bacquer D, Kaufman JM. Endogenous testosterone and cardiovascular disease in healthy men: A meta-Analysis. Heart 2011; 97: 870-5
3. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT et al. Clinical review: Endogenous testosterone and mortality in men: A systematic review and metaanalysis. J Clin Endocrinol Metab 2011; 96: 3007-19
4. Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: A systematic review and meta-Analysis. J Clin Endocrinol Metab 2010; 95: 2560-75
5. Liverman CT, Blazer DG. Testosterone and Aging: Clinical Research Directions. In: Board on Health Sciences Policy. Washington, DC: Institute of Medicine: The National Academies Press; 2004. p217
6. Haring R, Teumer A, Volker U, Dorr M, Nauck M et al. Mendelian randomization suggests non-causal associations of testosterone with cardiometabolic risk factors and mortality. Andrology 2013; 1: 17-23
7. Smith GD, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32: 1-22
8. Gray R, Wheatley K. How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant 1991; 7 (Suppl 3): 9-12
9. Smith GD, Timpson N, Ebrahim S. Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization. Ann Med 2008; 40: 524-41
10. Petra P, Stanczyk FZ, Namkung PC, Fritz MA, Novy ML. Direct effect of sex-steroid binding protein (SBP) of plasma on the metabolic clearance rate of testosterone in the rhesus macaque. J Steroid Biochem Mol Biol 1985; 22: 739-46
11. Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005; 122: 751-62
12. Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA. Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane. J Steroid Biochem Mol Biol 1999; 69: 481-5
13. Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA. Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine monophosphate. Steroids 1999; 64: 100-6
14. Ohlsson C, Wallaschofski H, Lunetta KL, Stolk L, Perry JR et al. Genetic determinants of serum testosterone concentrations in men. PLoS Genet 2011; 7: E1002313
15. Hackbarth JS, Hoyne JB, Grebe SK, Singh RJ. Accuracy of calculated free testosterone differs between equations and depends on gender and SHBG concentration. Steroids 2011; 76: 48-55
16. Ly LP, Sartorius G, Hull L, Leung A, Swerdloff RS et al. Accuracy of calculated free testosterone formulae in men. Clin Endocrinol (Oxf) 2010; 73: 382-8
17. Sartorius G, Ly LP, Sikaris K, McLachlan R, Handelsman DJ. Predictive accuracy and sources of variability in calculated free testosterone estimates. Ann Clin Biochem 2009; 46: 137-43
18. Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 2011; 40: 740-52
19. Haring R, Wallaschofski H, Nauck M, Felix SB, Schmidt CO et al. Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to its components. Exp Clin Endocrinol Diabetes 2010; 118: 685-91
20. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J. Androl 2009; 30: 1-9
21. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ et al. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010; 95: 2536-59
22. Handelsman DJ. Pharmacoepidemiology of testosterone prescribing in Australia, 1992-2010. Med J Aust 2012; 196: 642-5
23. Sartorius G, Spasevska S, Idan A, Turner L, Forbes E et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: The healthy man study. Clin Endocrinol (Oxf) 2012; 77: 755-63
24. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab 2012; 97: 2050-8
25. Wu FC. Caveat emptor: Does testosterone treatment reduce mortality in men? J Clin Endocrinol Metab 2012; 97: 1884-6